Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study will be to evaluate the efficacy of mecamylamine in reducing alcohol
consumption in smoking and non-smoking alcohol dependent patients.
We hypothesize that mecamylamine will result in a greater reduction of alcohol consumption
than placebo. We further hypothesize that mecamylamine will be effective in reducing both
alcohol consumption and smoking in a subset of alcoholics who also smoke.